Clinical Trials Logo

Meniere's Disease clinical trials

View clinical trials related to Meniere's Disease.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT02768662 Terminated - Meniere's Disease Clinical Trials

A 6-Month Extension Study of OTO-104 in Meniere's Disease

Start date: August 2016
Phase: Phase 3
Study type: Interventional

This is an open-label extension study of a single intratympanic injection of OTO-104 given every 3 months for a total of 2 injections. Subjects must have completed either Otonomy study 104-201403 (1-Year, Phase 2, Safety Study of OTO-104) or 104-201508 (Phase 3 Study of OTO-104) in order to be eligible for this open-label extension study.

NCT ID: NCT02740387 Terminated - Meniere's Disease Clinical Trials

Open Label Study of OTO-104 in Subjects With Meniere's Disease

Start date: June 2016
Phase: Phase 2
Study type: Interventional

This is a 1-year, multicenter, Phase 2, open-label safety study in subjects with unilateral Meniere's disease. Subjects will receive 1 intratympanic (IT) injection of 12 mg OTO-104 at 3-month intervals for a total of 4 injections total.

NCT ID: NCT02717442 Terminated - Meniere's Disease Clinical Trials

Study of OTO-104 in Subjects With Unilateral Meniere's Disease

AVERTS-2
Start date: March 21, 2016
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of OTO-104 for the treatment of Meniere's disease.

NCT ID: NCT02706730 Terminated - Meniere's Disease Clinical Trials

A 6-Month Extension Study of OTO-104 in Meniere's Disease

Start date: February 2016
Phase: Phase 3
Study type: Interventional

This is an open-label extension study of a single intratympanic injection of OTO-104 given every 3 months for a total of 2 injections. Subjects must have completed either Otonomy study 104-201102 (Phase 2b study of OTO-104) or 104-201506 (Phase 3 study of OTO-104) in order to be eligible for this open-label extension study.

NCT ID: NCT02530931 Terminated - Meniere's Disease Clinical Trials

Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Patients With Meniere's Disease

PROSPER
Start date: March 16, 2016
Phase: Phase 4
Study type: Interventional

- This prospective study aims to better characterize inner ear's perilymphatic structures with Magnetic Resonance Imaging using contrast media and delayed injection in patient's with Meniere's disease. - MR Perfusion Imaging will be assess in both cochlea as well - Primary auditory brain pathways will be evaluated through MR diffusion imaging

NCT ID: NCT01526408 Terminated - Meniere's Disease Clinical Trials

Famvir for Treatment of Hearing in Unilateral Meniere's Disease

Famvir
Start date: December 2011
Phase: Phase 3
Study type: Interventional

The specific aim of this study is to determine the efficacy of treatment with famciclovir in unilateral Meniere's Disease patients, specifically whether hearing can be improved. The investigators will determine the percentage of unilateral Meniere's Disease patients experiencing an absence of hearing fluctuation after 3 months of treatment with famciclovir as compared to the placebo arm.